Cytodyn Inc (CYDY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 05/31
| 08-2004 | 05-2004 | 02-2004 | 11-2003 | 08-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 76 | 187 | 175 | 12 | 0 |
| TOTAL | $86 | $203 | $175 | $12 | $0 |
| Non-Current Assets | |||||
| PPE Net | 6 | 3 | 2 | N/A | N/A |
| Other Non-Current Assets | 1 | 1 | 0 | 1 | 0 |
| TOTAL | $7 | $4 | $2 | $1 | $N/A |
| Total Assets | $93 | $207 | $177 | $13 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 72 | 72 | 72 | 77 | N/A |
| Accounts payable and accrued liabilities | 132 | 119 | 94 | 96 | 1 |
| Accrued Expenses | 9 | 17 | N/A | N/A | N/A |
| TOTAL | $213 | $207 | $166 | $203 | $1 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $213 | $207 | $166 | $203 | $1 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,069 | 8,069 | 8,019 | 6,253 | 1,780 |
| Common Shares | 1,916 | 1,916 | 211 | 42 | 12 |
| Retained earnings | -2,061 | -1,940 | -208 | -79 | -21 |
| TOTAL | $-120 | $0 | $11 | $-190 | $-1 |
| Total Liabilities And Equity | $93 | $207 | $177 | $13 | $0 |